Table 2 |
|||||||||
|
NNT and Drug Costs by Adverse Events |
|||||||||
| Event |
Placebo risk |
Treatment risk |
ARR |
NNT |
(95% CI) |
5-Year NNT |
5-year Rx Cost Per Patient |
Total Cost |
Incremental Cost |
|
|
|||||||||
| Death |
0.1002 |
0.0858 |
0.0144 |
69 |
(31 – 319) |
62 |
$456 |
$28,284 |
$13,230 |
| CVD |
0.1746 |
0.1147 |
0.0599 |
17 |
(12 – 26) |
15 |
$456 |
$6,843 |
- |
| Stroke |
0.0705 |
0.0433 |
0.0272 |
37 |
(24 – 76) |
33 |
$456 |
$15,055 |
$0 (base) |
| MI |
0.0312 |
0.0202 |
0.011 |
91 |
(48 – 740) |
82 |
$456 |
$37,408 |
$22,354 |
| CHF |
0.0397 |
0.0198 |
0.0199 |
50 |
(33 – 103) |
45 |
$456 |
$20,529 |
$5,474 |
|
|
|||||||||
|
Chen et al. Cost Effectiveness and Resource Allocation 2005 3:2 doi:10.1186/1478-7547-3-2 |
|||||||||
